(Q28294130)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869469

20 July 2024

author name string

Anne Konkel

1

0 references

Wolf-Hagen Schunck

2

0 references

language of work or name

English

0 references

publication date

January 2011

0 references

30 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

20869469

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869469

full work available at URL

20 July 2024

https://api.elsevier.com/content/article/PII:S157096391000258X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

https://api.elsevier.com/content/article/PII:S157096391000258X?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Biochimica et Biophysica Acta

20 July 2024

published in

0 references

volume

1814

0 references

issue

1

0 references

page(s)

210-22

0 references

cites work

Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function

1

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Dietary fat quality for optimal health and well-being: overview of recommendations

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Omega-3 fatty acids: cardiovascular benefits, sources and sustainability

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Essentiality of fatty acids

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cyclooxygenases: structural, cellular, and molecular biology

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Prostaglandins and leukotrienes: advances in eicosanoid biology

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure.

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

P-450 metabolites of arachidonic acid in the control of cardiovascular function

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-HETE and the kidney: resolution of old problems and new beginnings

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxygenase pathways of arachidonic acid metabolism

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Vascular cytochrome p450 enzymes: physiology and pathophysiology.

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Distribution, interconversion, and dose response of n-3 fatty acids in humans

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Alpha-linolenic acid metabolism in men and women: nutritional and biological implications.

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Gender differences in the n-3 fatty acid content of tissues

20 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

20 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Bioactive dietary long-chain fatty acids: emerging mechanisms of action.

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The biochemistry of n-3 polyunsaturated fatty acids

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

n-3 fatty acids and gene expression

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

20 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The opposing effects of n-3 and n-6 fatty acids

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors

20 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid.

20 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes

20 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain

20 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart

20 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.

20 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.

20 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

20 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform

20 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity

20 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Dexamethasone induces bisallylic hydroxylation of polyunsaturated fatty acids by rat liver microsomes

20 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes

20 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS

20 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

7-HETE, 10-HETE, and 13-HETE Are Major Products of NADPH-Dependent Arachidonic Acid Metabolism in Rat Liver Microsomes: Analysis of Their Stereochemistry, and the Stereochemistry of Their Acid-Catalyzed Rearrangement

20 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20 July 2024

Phospholipase A2 enzymes

67

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases.

20 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Eicosanoid signalling pathways in the heart

20 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450-derived renal HETEs: storage and release

20 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells.

20 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders

20 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion

20 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The biogenesis of chylomicrons

20 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance

20 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The lung HETEs (and EETs) up.

20 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response

20 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels

20 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats

20 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology

20 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets

20 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Predominant Expression of an Arachidonate Epoxygenase in Islets of Langerhans Cells in Human and Rat Pancreas

20 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?

20 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.

20 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosanoid signaling in CNS function and disease

20 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Eicosanoid regulation of the renal vasculature

20 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase

20 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current

20 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus

20 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.

20 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells

20 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension

20 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat

20 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension

20 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway

20 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke

20 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.

20 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats

20 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans

20 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials.

20 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure

20 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

20 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides

20 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-HETE agonists and antagonists in the renal circulation

20 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats

20 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

20 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors

20 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450 2C is an EDHF synthase in coronary arteries

20 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice

20 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways.

20 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation

20 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid

20 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC

20 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.

20 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes.

20 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids

20 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

20 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury

20 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts

20 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosatrienoic acids, cell signaling and angiogenesis

20 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Action of epoxyeicosatrienoic acids on cellular function

20 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.

20 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system

20 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids

20 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

20 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

20 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases

20 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury

20 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats.

20 July 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles

20 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

20 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo

20 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

20 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.

20 July 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

20 July 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome p450 epoxygenase promotes human cancer metastasis

20 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation

20 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform

20 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

A biosynthetic pathway generating 12-hydroxy-5,8,14-eicosatrienoic acid from arachidonic acid is active in mouse skin microsomes

20 July 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase

20 July 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

20 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s

20 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase

20 July 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cloning of CYP2J2 gene and identification of functional polymorphisms

20 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities

20 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxidation of C18 unsaturated fatty acids by cytochromes P4502C2 and P4502CAA

20 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns

20 July 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats breathing pure oxygen and from patients with the adult respiratory distress syndrome

20 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Biosynthesis of leukotoxin, 9,10-epoxy-12 octadecenoate, by leukocytes in lung lavages of rat after exposure to hyperoxia

20 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Neutrophils biosynthesize leukotoxin, 9, 10-epoxy-12-octadecenoate

20 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Neutrophil microsomes biosynthesize linoleate epoxide (9,10-epoxy-12-octadecenoate), a biological active substance

20 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Hydroxyl radical and leukotoxin biosynthesis in neutrophil plasma membrane

20 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Leukotoxin, 9,10-epoxy-12-octadecenoate inhibits mitochondrial respiration of isolated perfused rat lung

20 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Endothelin-1 potentiates leukotoxin-induced edematous lung injury

20 July 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Neutrophil-derived epoxide, 9,10-epoxy-12-octadecenoate, induces pulmonary edema

20 July 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Leukotoxin, 9, 10-epoxy-12-octadecenoate, causes cardiac failure in dogs.

20 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs

20 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome

20 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytotoxicity of linoleic acid diols to renal proximal tubular cells

20 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Effects of linoleic acid metabolites on electrical activity in adult rat ventricular myocytes

20 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells

20 July 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells.

20 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Linoleic acid metabolites act to increase contractility in isolated rat heart

20 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Linoleic acid epoxide promotes the maintenance of mitochondrial function and active Na+ transport following hypoxia

20 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation

20 July 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

20 July 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS.

20 July 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Salt loading increases urinary excretion of linoleic acid diols and triols in healthy human subjects

20 July 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading.

20 July 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive

20 July 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model

20 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Docosatetraenoic acid in endothelial cells: formation, retroconversion to arachidonic acid, and effect on prostacyclin production

20 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders

20 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Adrenic acid metabolites as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors

20 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Metabolism of adrenic acid to vasodilatory 1alpha,1beta-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries

20 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

EET homologs potently dilate coronary microvessels and activate BK(Ca) channels

20 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Oxidation of 5,8,11,14,17-eicosapentaenoic acid by hepatic and renal microsomes.

20 July 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators

20 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production

20 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids

20 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.

20 July 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns

20 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.

20 July 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.

20 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids

20 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8

20 July 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily

20 July 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Urinary excretion of diols derived from eicosapentaenoic acid during N-3 fatty acid ingestion by man

20 July 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters

20 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents.

20 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels

20 July 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study

20 July 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung

20 July 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

20 July 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha

20 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase

20 July 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha

20 July 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo

20 July 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology

20 July 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

20 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids

20 July 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid

20 July 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site

20 July 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.BBAPAP.2010.09.009

20 July 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20869469

1 reference

Consolidated OpenCitations Corpus – April 2017